Therapy for small cell lung cancer using carboplatin, ifosfamide, etoposide (without dose reduction), mid-cycle vincristine with thoracic and cranial irradiation
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (14) , 2085-2090
- https://doi.org/10.1016/0959-8049(94)00363-a
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Neurological and cognitive impairment in long-term survivors of small cell lung cancerEuropean Journal Of Cancer, 1994
- Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.Journal of Clinical Oncology, 1991
- Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.Journal of Clinical Oncology, 1990
- An overview of prognostic factors in small cell lung cancerBritish Journal of Cancer, 1990
- Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchusBritish Journal of Cancer, 1989
- Cisplatin and etoposide (VP-16) as a single regimen for small cell lung cancer. A phase II trialCancer, 1989
- Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.Journal of Clinical Oncology, 1987
- Prognostic factors in small cell lung cancer: A simple prognostic index is better than conventional stagingEuropean Journal of Cancer and Clinical Oncology, 1987
- Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patientsInternational Journal of Cancer, 1987
- Radiation therapy of cerebral metastases: a randomized prospective clinical trialInternational Journal of Radiation Oncology*Biology*Physics, 1977